SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 189.59 |
| Enterprise Value ($M) | 135.46 |
| Book Value ($M) | 82.95 |
| Book Value / Share | 1.25 |
| Price / Book | 2.25 |
| NCAV ($M) | 80.81 |
| NCAV / Share | 1.21 |
| Price / NCAV | 2.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.54 |
| Return on Assets (ROA) | -0.61 |
| Return on Equity (ROE) | -0.75 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.08 |
| Current Ratio | 7.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 95.05 |
| Assets | 97.19 |
| Liabilities | 14.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.68 |
| Operating Income | -48.65 |
| Net Income | -45.43 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -37.69 |
| Cash from Investing | 13.73 |
| Cash from Financing | 53.78 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Pfizer Inc | 3.60 | 0.00 | |
| 13G/A | BlackRock, Inc. | 4.30 | 3.85 | |
| 13G | Commodore Capital Lp | 8.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 173,695 | 1,775,705 | 9.78 | |
| 294,749 | 1,379,458 | 21.37 | |
| 353,224 | 1,263,750 | 27.95 | |
| 545,583 | 1,995,995 | 27.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COYA – Coya Therapeutics, Inc. | CPRX – Catalyst Pharmaceuticals, Inc. |
| CRBP – Corbus Pharmaceuticals Holdings, Inc. | CRIS – Curis, Inc. |
| CRVO – CervoMed Inc. |
Financial data and stock pages provided by
Fintel.io